CRYSTAL TRAVIS: Open Payments
NPI 1003255266 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84,087 in 316 payments from 14 companies in 2025. Trend: 2023 $74,456 · 2024 $70,018 · 2025 $84,087
Speaker / faculty: $48,728Honoraria: $19,125Travel & lodging: $7,046Food & beverage: $4,951Consulting: $4,024Education: $213
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 108 | $40,755 |
| Axsome Therapeutics, Inc. | 65 | $21,658 |
| ABBVIE INC. | 53 | $12,185 |
| Vanda Pharmaceuticals Inc. | 30 | $8,336 |
| Teva Pharmaceuticals USA, Inc. | 12 | $394 |
| Otsuka America Pharmaceutical, Inc. | 19 | $326 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $172 |
| Alkermes, Inc. | 5 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
Products named: COBENFY, Auvelity, FANAPT, VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, ARISTADA.
Industry payments across OH — which companies pay providers there.
